CR20110271A - Método para reducir el riesgo de trombocitopenia y tombocitopenia asociada con mortalidad - Google Patents

Método para reducir el riesgo de trombocitopenia y tombocitopenia asociada con mortalidad

Info

Publication number
CR20110271A
CR20110271A CR20110271A CR20110271A CR20110271A CR 20110271 A CR20110271 A CR 20110271A CR 20110271 A CR20110271 A CR 20110271A CR 20110271 A CR20110271 A CR 20110271A CR 20110271 A CR20110271 A CR 20110271A
Authority
CR
Costa Rica
Prior art keywords
risk
mortality
trombocitopenia
tombocitopenia
reducing
Prior art date
Application number
CR20110271A
Other languages
English (en)
Inventor
Marco Valgimigli
Original Assignee
Iroko Cardio Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42198725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20110271(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Iroko Cardio Llc filed Critical Iroko Cardio Llc
Publication of CR20110271A publication Critical patent/CR20110271A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se describen métodos para reducir el risgo de mortalidad y morbilidad asociadas a trombocitopenia y para reducir el risgo de trombocitopenia en pacientes cuyo tratamiento requiere inhibición de la agragación plaquetaria.
CR20110271A 2008-11-21 2011-05-23 Método para reducir el riesgo de trombocitopenia y tombocitopenia asociada con mortalidad CR20110271A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11697608P 2008-11-21 2008-11-21

Publications (1)

Publication Number Publication Date
CR20110271A true CR20110271A (es) 2011-10-13

Family

ID=42198725

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20110271A CR20110271A (es) 2008-11-21 2011-05-23 Método para reducir el riesgo de trombocitopenia y tombocitopenia asociada con mortalidad

Country Status (18)

Country Link
US (1) US20120059036A1 (es)
EP (1) EP2355824A4 (es)
KR (1) KR20110108330A (es)
AU (1) AU2009318101A1 (es)
BR (1) BRPI0920984A2 (es)
CL (1) CL2011001175A1 (es)
CO (1) CO6390039A2 (es)
CR (1) CR20110271A (es)
DO (1) DOP2011000149A (es)
EC (1) ECSP11011152A (es)
MA (1) MA32820B1 (es)
MX (1) MX2011005376A (es)
NI (1) NI201100101A (es)
PE (1) PE20110946A1 (es)
SV (1) SV2011003915A (es)
TN (1) TN2011000256A1 (es)
WO (1) WO2010059244A2 (es)
ZA (1) ZA201103741B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101996880B1 (ko) 2018-03-16 2019-07-05 경성대학교 산학협력단 컴파운드 k를 유효성분으로 포함하는 혈소판 감소증 예방 또는 치료용 조성물
CN112441962A (zh) * 2019-09-04 2021-03-05 武汉武药科技有限公司 替罗非班及其纯化方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ239846A (en) 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof
ATE381347T1 (de) * 2001-01-26 2008-01-15 Schering Corp Kombinationen von ezetimibe und aspirin zur behandlung von kardiovaskulären erkrankungen
US6770660B2 (en) 2002-05-06 2004-08-03 Artery Llc Method for inhibiting platelet aggregation
DE60305113T2 (de) * 2002-09-09 2006-12-07 Trigen Ltd. Borsäuresalze und deren Verwendung in der Bereitstellung von Medikamente für die Thrombosebehandlung
DE602005019874D1 (de) * 2004-05-12 2010-04-22 Bristol Myers Squibb Co Für die behandlung von thrombotischen leiden geeignete harnstoffantagonisten des p2y1-rezeptors
WO2006044000A1 (en) * 2004-10-12 2006-04-27 Decode Genetics Sulfonamide pert-substituted bicyclics for occlusive artery disease

Also Published As

Publication number Publication date
NI201100101A (es) 2011-12-19
WO2010059244A2 (en) 2010-05-27
WO2010059244A3 (en) 2010-10-14
BRPI0920984A2 (pt) 2017-07-11
EP2355824A2 (en) 2011-08-17
ECSP11011152A (es) 2011-09-30
DOP2011000149A (es) 2011-10-31
TN2011000256A1 (en) 2012-12-17
SV2011003915A (es) 2011-07-01
MX2011005376A (es) 2011-10-19
PE20110946A1 (es) 2012-01-05
CO6390039A2 (es) 2012-02-29
KR20110108330A (ko) 2011-10-05
AU2009318101A1 (en) 2010-05-27
CL2011001175A1 (es) 2011-11-11
ZA201103741B (en) 2012-01-25
MA32820B1 (fr) 2011-11-01
US20120059036A1 (en) 2012-03-08
EP2355824A4 (en) 2012-11-07

Similar Documents

Publication Publication Date Title
CA145514S (en) Pump
GT201400033A (es) Pirimidinas anilladas sustituidas y uso de las mismas
CA142228S (en) Luminaire
AU352243S (en) Hand tightened hydraulic fitting
RS53467B (en) USE OF AMISULPRID FOR TREATMENT OF Nausea and Vomiting Caused by Chemotherapy
UY33754A (es) Monobactamas
UY34124A (es) Cerramiento y método para conformarlo
GT200800068S (es) Carena para motocicleta
CA144971S (en) Eyeglasses
UY33949A (es) Procedimiento para producir semilla f1 de arroz, semilla f1 de arroz y línea macho estéril de arroz
UY34186A (es) ?procedimiento para revestir una superficie con micelas y superficie revestida con micelas?.
CA143485S (en) Display box
CA145174S (en) Can
AR082215A1 (es) Composicion farmaceutica agradable al paladar
CA145176S (en) Can
CA145175S (en) Can
UY34268A (es) Métodos para aumentar el contenido de proteínas,aceites y/o aminoácidos en una planta
CL2015003106A1 (es) Método para mejorar la resorción de minerales en peces y crustáceos de cría.
EA201200017A1 (ru) Новая кристаллическая форма пемироласта
CR20110271A (es) Método para reducir el riesgo de trombocitopenia y tombocitopenia asociada con mortalidad
AR095594A1 (es) Métodos para tratar infecciones en pacientes con sobrepeso y obesos usando antibióticos
UY34140A (es) Mejoras en el riego
RS54412B1 (en) COMPOSITION OF BEE HONEY AND L-ALANYL-L-GLUTAMINE
CA141191S (en) Packaging
UY34340A (es) Plantas que tienen rasgos relacionados al stress y metodos para producir las mismas.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)